Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
OBJECTIVES: To evaluate the association between improvements in physical function, fatigue and pain and improvements in productivity at work and at home in patients treated with certolizumab pegol (CZP) in combination with MTX. METHODS: Physical function, fatigue and pain were assessed in two CZP c...
主要な著者: | Hazes, J, Taylor, P, Strand, V, Purcaru, O, Coteur, G, Mease, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2010
|
類似資料
-
Certolizumab pegol in therapy for rheumatoid arthritis
著者:: Galina Viktorovna Lukina, 等
出版事項: (2012-06-01) -
COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
著者:: Purcaru, O, 等
出版事項: (2010) -
QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
著者:: Vera Nikolayevna Amirdjanova, 等
出版事項: (2012-10-01) -
Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
著者:: M Connock, 等
出版事項: (2010-10-01) -
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
著者:: Ruiz Garcia, V, 等
出版事項: (2014)